Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, par value $ 0.000001 per share
-
Shares outstanding
-
6.51M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
2.04M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$15.5M
-
Value change
-
+$13.6M
-
Number of buys
-
26
-
Price
-
$7.62
Significant Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) as of Q4 2023
27 filings reported holding TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share as of Q4 2023.
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.04M shares
of 6.51M outstanding shares and own 31.32% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (624K shares), CPMG Inc (411K shares), Cable Car Capital LLC (258K shares), VANGUARD GROUP INC (130K shares), Nantahala Capital Management, LLC (127K shares), RENAISSANCE TECHNOLOGIES LLC (114K shares), MARSHALL WACE, LLP (60.6K shares), TWO SIGMA INVESTMENTS, LP (50.8K shares), MILLENNIUM MANAGEMENT LLC (49.7K shares), and BlackRock Inc. (37.6K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.